We are live on ! Find out more
CPA

Capital Performance Advisors Portfolio holdings

AUM $1.5B
1-Year Est. Return 21.4%
This Fund
S&P 500
This Quarter Est. Return
+7.04%
1 Year Est. Return
+21.4%
3 Year Est. Return
+61.53%
5 Year Est. Return
10 Year Est. Return
AUM
$329M
AUM Growth
+$65.6M
Cap. Flow
+$47.9M
Cap. Flow %
14.56%
Top 10 Hldgs %
61.59%
Holding
2,901
New
2,799
Increased
53
Reduced
27
Closed
2

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$772K
2
NVDA icon
NVIDIA
NVDA
+$662K
3
AAPL icon
Apple
AAPL
+$589K
4
MSFT icon
Microsoft
MSFT
+$568K
5
AVGO icon
Broadcom
AVGO
+$431K

Sector Composition

Rank Sector Weight
1 Technology 10.08%
2 Financials 4.66%
3 Consumer Discretionary 2.92%
4 Healthcare 2.04%
5 Industrials 1.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RITM icon
2626
Rithm Capital
RITM
$5.15B
$148 ﹤0.01%
+13
New +$148
RELY icon
2627
Remitly
RELY
$4.77B
$147 ﹤0.01%
+11
New +$149
BOLD
2628
Boundless Bio
BOLD
$55.7M
$146 ﹤0.01%
+42
New +$152
MOND
2629
DELISTED
Mondee Holdings, Inc. Class A Common Stock
MOND
$146 ﹤0.01%
+105
New +$222
NMRA icon
2630
Neumora Therapeutics
NMRA
$308M
$145 ﹤0.01%
+11
New +$128
IOT icon
2631
Samsara
IOT
$20.6B
$144 ﹤0.01%
+3
New +$122
TALK icon
2632
Talkspace
TALK
$874M
$144 ﹤0.01%
+69
New +$135
OMER icon
2633
Omeros
OMER
$821M
$143 ﹤0.01%
+36
New +$154
KYMR icon
2634
Kymera Therapeutics
KYMR
$9.05B
$142 ﹤0.01%
+3
New +$132
LENZ
2635
LENZ Therapeutics
LENZ
$179M
$142 ﹤0.01%
+6
New +$133
TELO icon
2636
Telomir Pharmaceuticals
TELO
$84.6M
$141 ﹤0.01%
+22
New +$107
VALU icon
2637
Value Line
VALU
$352M
$140 ﹤0.01%
+3
New +$132
GDRX icon
2638
GoodRx Holdings
GDRX
$1.03B
$139 ﹤0.01%
+20
New +$157
NG icon
2639
NovaGold Resources
NG
$2.62B
$139 ﹤0.01%
+34
New +$144
BBW icon
2640
Build-A-Bear
BBW
$428M
$137 ﹤0.01%
+4
New +$113
LYRA
2641
DELISTED
LYRA THERAPEUTICS INC
LYRA
$137 ﹤0.01%
+11
New +$162
PLXS icon
2642
Plexus
PLXS
$6.78B
$137 ﹤0.01%
+1
New +$121
RC
2643
Ready Capital
RC
$265M
$137 ﹤0.01%
+18
New +$153
EVTC icon
2644
Evertec
EVTC
$1.88B
$136 ﹤0.01%
+4
New +$133
LNKB
2645
DELISTED
LINKBANCORP
LNKB
$135 ﹤0.01%
+21
New +$138
PRPL icon
2646
Purple Innovation
PRPL
$35.8M
$134 ﹤0.01%
+5
New +$144
DGICA icon
2647
Donegal Group Class A
DGICA
$701M
$133 ﹤0.01%
+9
New +$130
SES icon
2648
SES AI
SES
$205M
$132 ﹤0.01%
+206
New +$215
NKTX icon
2649
Nkarta
NKTX
$162M
$131 ﹤0.01%
+29
New +$165
FHTX icon
2650
Foghorn Therapeutics
FHTX
$305M
$130 ﹤0.01%
+14
New +$101

Similar funds

Capital Performance Advisors's Q3 2024 Portfolio in Review

As of Q3 2024, Capital Performance Advisors held 2,901 positions worth $329M, up 25% from $263M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Capital Performance Advisors deployed $47.9M of net new capital in Q3 2024, opening 2,799 new positions and adding to 53 existing holdings. Its largest new stake was Broadcom: 2,686 shares worth $463K.

By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 8.6% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Dimensional US Core Equity 2 ETF, an estimated $521K trimmed.

  • Capital Performance Advisors's largest Q3 2024 buy was Broadcom: 2,686 shares worth $463K.
  • Capital Performance Advisors added most to Amazon in Q3 2024, an estimated $772K increase.
  • Capital Performance Advisors's biggest Q3 2024 reduction was Dimensional US Core Equity 2 ETF, cutting an estimated $521K.
  • Capital Performance Advisors fully exited Dimensional US Core Equity 1 ETF in Q3 2024, selling an estimated $497K.
  • Capital Performance Advisors's ten largest holdings make up 62% of its $329M portfolio in Q3 2024.
  • Capital Performance Advisors opened 2,799 new positions and closed 2 in Q3 2024.
  • Capital Performance Advisors's portfolio value rose 25% quarter-over-quarter to $329M.

Based on Capital Performance Advisors's 13F filing for Q3 2024, filed 1 Nov 2024.